IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Galmed Pharmaceuticals ORD (NMS)

CUSIP: 001131390 | 1 institutional holders

Quarters

Q3 2020Q2 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2020

Rock Creek Group LLC75,000
0.0% of portfolio›$265
StyleTurnoverLocationFiled
Rock Creek Group LLC
75,000$2650.0%ETFMediumWashington, DC2020-10-30